Israeli drug giant Teva to move offices to Tel Aviv - Israel News - The Jerusalem Post
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #q3results #earnings #tevapharm
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva meets profit expectations but misses on revenue - Globes
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Fresh woes emerge as Teva plunges to new lows - Globes
Teva Pharmaceuticals - Teva: Love doesn't take a break | Clios
Teva: Our Biosimilars Strategy Has Been Fragmented, We Want To Be Global :: Generics Bulletin
Global CGRP Inhibitor Market Research Report 2023: A $5.6 Billion Market by 2029 Featuring Key Players - Eli Lilly and Co, Pfizer, Teva Pharmaceuticals, Lundbeck, AbbVie, Amgen, & Novartis
Teva Active Pharmaceutical Ingredients on LinkedIn: #regulatoryaffairs #webinar
Teva targets sub-Saharan Africa - Globes
Teva enlarges workforce for first time since 2016 - Globes
Novavax, Fujifilm end COVID vaccine production contract—Fierce Pharma Asia
Teva boosted as FDA delays generic Copaxone - Globes
Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel